FDA panel gives nod to Moderna flu shot

From The Hill

Presented by Planned Parenthood {beacon} Healthcare Health Care PRESENTED BY The Big Story FDA panel gives nod to Moderna flu shot The FDA’s independent vaccine advisors voted unanimously 9-0 that the benefits outweigh the risks for Moderna’s mFlusiva shot in people ages 50 to 64 as well as 65 and older. The shot is…

Source Author
Author: Source Author

Written by

Nathaniel Weixel

in

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts